These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8546206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells.
    Piao X, Bernstein A.
    Blood; 1996 Apr 15; 87(8):3117-23. PubMed ID: 8605325
    [Abstract] [Full Text] [Related]

  • 7. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.
    Ohmori K, Kawarai S, Yasuda N, Tanaka A, Matsuda H, Nishimura R, Sasaki N, Tsujimoto H, Masuda K.
    Vet Immunol Immunopathol; 2008 Nov 15; 126(1-2):43-53. PubMed ID: 18687474
    [Abstract] [Full Text] [Related]

  • 8. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
    Pedersen M, Rönnstrand L, Sun J.
    Cell Signal; 2009 Mar 15; 21(3):413-8. PubMed ID: 19049823
    [Abstract] [Full Text] [Related]

  • 9. Deficiency of Trp53 rescues the male fertility defects of Kit(W-v) mice but has no effect on the survival of melanocytes and mast cells.
    Jordan SA, Speed RM, Bernex F, Jackson IJ.
    Dev Biol; 1999 Nov 01; 215(1):78-90. PubMed ID: 10525351
    [Abstract] [Full Text] [Related]

  • 10. STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity.
    Ning ZQ, Li J, McGuinness M, Arceci RJ.
    Oncogene; 2001 Jul 27; 20(33):4528-36. PubMed ID: 11494148
    [Abstract] [Full Text] [Related]

  • 11. Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirement.
    Caruana G, Cambareri AC, Gonda TJ, Ashman LK.
    Oncogene; 1998 Jan 15; 16(2):179-90. PubMed ID: 9464535
    [Abstract] [Full Text] [Related]

  • 12. Proliferation and differentiation of spermatogonial stem cells in the w/wv mutant mouse testis.
    Ohta H, Tohda A, Nishimune Y.
    Biol Reprod; 2003 Dec 15; 69(6):1815-21. PubMed ID: 12890724
    [Abstract] [Full Text] [Related]

  • 13. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors.
    Isozaki K, Terris B, Belghiti J, Schiffmann S, Hirota S, Vanderwinden JM.
    Am J Pathol; 2000 Nov 15; 157(5):1581-5. PubMed ID: 11073817
    [Abstract] [Full Text] [Related]

  • 14. Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases.
    Eklund KK, Ghildyal N, Austen KF, Stevens RL.
    J Immunol; 1993 Oct 15; 151(8):4266-73. PubMed ID: 7691943
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
    Mirmonsef P, Shelburne CP, Fitzhugh Yeatman C, Chong HJ, Ryan JJ.
    J Immunol; 1999 Sep 01; 163(5):2530-9. PubMed ID: 10452990
    [Abstract] [Full Text] [Related]

  • 16. The role of Ets-1 in mast cell granulocyte-macrophage colony-stimulating factor expression and activation.
    McKinlay LH, Tymms MJ, Thomas RS, Seth A, Hasthorpe S, Hertzog PJ, Kola I.
    J Immunol; 1998 Oct 15; 161(8):4098-105. PubMed ID: 9780181
    [Abstract] [Full Text] [Related]

  • 17. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
    Samayawardhena LA, Hu J, Stein PL, Craig AW.
    Cell Signal; 2006 Sep 15; 18(9):1447-54. PubMed ID: 16442778
    [Abstract] [Full Text] [Related]

  • 18. A transforming mutation enhances the activity of the c-Kit soluble tyrosine kinase domain.
    Lam LP, Chow RY, Berger SA.
    Biochem J; 1999 Feb 15; 338 ( Pt 1)(Pt 1):131-8. PubMed ID: 9931308
    [Abstract] [Full Text] [Related]

  • 19. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo.
    Mackenzie MA, Jordan SA, Budd PS, Jackson IJ.
    Dev Biol; 1997 Dec 01; 192(1):99-107. PubMed ID: 9405100
    [Abstract] [Full Text] [Related]

  • 20. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S, Bergholz U, Jücker M, McCubrey JA, Trümper L, Stocking C, Bäsecke J.
    Oncogene; 2008 Jul 03; 27(29):4096-106. PubMed ID: 18317450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.